This page shows the latest Intercept news and features for those working in and with pharma, biotech and healthcare.
Intercept Pharmaceuticals is awaiting a US Food and Drug Administration (FDA) review of its obeticholic acid drug Ocaliva in NASH after a number of delays, first in January and then again
Another potential competitor – Intercept Pharmaceuticals – is still awaiting an FDA review of its obeticholic acid drug Ocaliva in NASH after a number of delays, first in January and then again in
Another potential treatment for NASH – from Intercept – is currently under review with the US Food and Drug Administration (FDA). ... additional information provided in response to FDA requests,” Intercept wrote in the filing at the time.
Intercept confirmed the delay in a filing with the US Securities &Exchange Commission last week. ... additional information provided in response to FDA requests,” Intercept wrote in the filing.
Meanwhile, Intercept Pharma’s obeticholic acid (OCA) is under priority review at the FDA for the treatment of liver fibrosis due to NASH, and could become the first drug to treat
1R inhibition intercepts the migration of inflammatory cells to the gut.
More from news
Approximately 10 fully matching, plus 19 partially matching documents found.
In this endeavour to eradicate or intercept cancer, it is our duty to account for distinct differences in people’s ‘-omics’ spectrum, but also importantly in their clinical, psychosocial and professional
In Europe Cerus expects to apply for a CE Mark for the Intercept RBC System in the second half of 2016. ... collaboration, licence. 200. Cerus/ BARDA. Intercept, pathogen reduction technology for blood transfusions including Zika virus.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Doyle - who joins the group from Intercept Pharmaceuticals where he was executive director of commercial operations and marketing - will be at the forefront of a number of key accounts to help
He currently serves as a director at Amicus Therapeutics, Intercept Pharmaceuticals and Ophthotech Corporation.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
In this episode of Impetus Digital's Fireside Chat, I talk to Brian Canestraro, General Manager at Intercept Pharmaceuticals.
Develop your communication for each channel specifically. Intercept testing: show the ad to your mother, your child, a co-worker down the hall.
Our survey, carried out using a mobile research intercept method, found that, unfortunately, memory aids can give patients the false reassurance that they are more compliant than they actually are.
More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.
Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...